infantile hemangiomas
Conditions
Interventions
diprosan group:injection of diprosan
triamcinolone acetonide:injection of triamcinolone acetonide
Sponsors
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: 1. diagnosis of superficial infantile hemangiomas, the age of less than 6 months, male or female; 2. superficial infantile hemangiomas have not received other treatment; 3. voluntarily signed by the person or guardian after learning about the treatment plan and risk Informed consent, willing to accept a controlled trial, and with follow-up.
Exclusion criteria
Exclusion criteria: 1. endocrine disease; 2. severe heart disease or asthma; 3. glucocorticoid contraindications; 4. wounds in the lesion area, or patients with epidermal ulceration.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS; | — |
Countries
China
Contacts
Public ContactLi Wei
Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed